teknova makes prepared media for bacteria and yeast applications. we have a full portfolio that includes plated and liquid growth media, as well as dry microbiological media that is available both bottled and in our propietary soluble pouch. we also have a full range of buffers, reagents and solutions, and everything we carry is available in custom formulations in order to optimize our products specifically to each of our customer's application. we have done it all before, and we challenge our customers to come up with a formulation that is a first time request.
Company profile
Ticker
TKNO
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
943368109
TKNO stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
27 Mar 24
8-K
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 24
DEF 14C
Information statement
21 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
16 Jan 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Teknova Reports Third Quarter 2023 Financial Results
9 Nov 23
424B3
Prospectus supplement
9 Nov 23
EFFECT
Notice of effectiveness
8 Nov 23
CORRESP
Correspondence with SEC
3 Nov 23
UPLOAD
Letter from SEC
2 Nov 23
Transcripts
TKNO
Earnings call transcript
2023 Q4
11 Mar 24
TKNO
Earnings call transcript
2023 Q3
9 Nov 23
TKNO
Earnings call transcript
2023 Q2
10 Aug 23
TKNO
Earnings call transcript
2023 Q1
10 May 23
TKNO
Earnings call transcript
2022 Q4
15 Mar 23
TKNO
Earnings call transcript
2022 Q3
13 Nov 22
TKNO
Earnings call transcript
2022 Q3
9 Nov 22
TKNO
Earnings call transcript
2022 Q2
10 Aug 22
TKNO
Earnings call transcript
2022 Q1
15 May 22
TKNO
Earnings call transcript
2021 Q4
16 Mar 22
Latest ownership filings
4
Paul David Grossman
27 Feb 24
SC 13G/A
Telegraph Hill Partners IV, L.P.
14 Feb 24
4
Robert McNamara
6 Feb 24
4
Alexander Vos
2 Feb 24
4
BRETT ROBERTSON
2 Feb 24
4
Ken Gelhaus
1 Dec 23
4
Lisa Hood
15 Nov 23
SC 13G/A
Telegraph Hill Partners IV, L.P.
6 Oct 23
4
Change in insider ownership
21 Sep 23
4
Damon Terrill
21 Sep 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 32.11 mm | 32.11 mm | 32.11 mm | 32.11 mm | 32.11 mm | 32.11 mm |
Cash burn (monthly) | (no burn) | 1.48 mm | 3.38 mm | 3.37 mm | 1.46 mm | 2.00 mm |
Cash used (since last report) | n/a | 10.19 mm | 23.31 mm | 23.24 mm | 10.07 mm | 13.76 mm |
Cash remaining | n/a | 21.92 mm | 8.80 mm | 8.87 mm | 22.04 mm | 18.35 mm |
Runway (months of cash) | n/a | 14.8 | 2.6 | 2.6 | 15.1 | 9.2 |
Institutional ownership, Q3 2023
75.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 29 |
Opened positions | 3 |
Closed positions | 5 |
Increased positions | 8 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 14.80 bn |
Total shares | 30.83 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Telegraph Hill Partners IV | 25.62 mm | $45.86 mm |
Millennium Management | 1.76 mm | $4.92 bn |
Balyasny Asset Management | 1.07 mm | $2.98 bn |
Platinum Investment Management | 834.53 k | $2.33 bn |
Vanguard | 402.38 k | $1.12 bn |
Redmile | 284.56 k | $793.93 mm |
Conestoga Capital Advisors | 237.73 k | $663.26 mm |
Parkman Healthcare Partners | 233.75 k | $652.15 mm |
Geode Capital Management | 73.90 k | $206.23 mm |
Bridgeway Capital Management | 70.00 k | $195.30 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Nov 23 | Ken Gelhaus | Common Stock | Buy | Acquire P | No | No | 1.734 | 3,587 | 6.22 k | 22,924 |
14 Nov 23 | Lisa Hood | Common Stock | Other | Dispose J | No | No | 0 | 15,000 | 0.00 | 18,834 |
19 Sep 23 | J Matthew Mackowski | Common Stock | Buy | Acquire P | Yes | No | 1.85 | 810,810 | 1.50 mm | 810,810 |
19 Sep 23 | Stephen Gunstream | Common Stock | Buy | Acquire P | No | No | 1.85 | 54,054 | 100.00 k | 162,852 |
19 Sep 23 | Damon Terrill | Common Stock | Buy | Acquire P | No | No | 1.85 | 27,027 | 50.00 k | 41,027 |
News
12 Health Care Stocks Moving In Tuesday's Intraday Session
26 Mar 24
BTIG Downgrades Alpha Teknova to Neutral
12 Mar 24
Alpha Teknova Sees FY24 Revenue $35M-$38M Vs $41.49M Est.
11 Mar 24
Recap: Alpha Teknova Q4 Earnings
11 Mar 24
Alpha Teknova Q4 2023 GAAP EPS $(0.26) Misses $(0.21) Estimate, Sales $7.867M Miss $8.325M Estimate
11 Mar 24